Citation Impact
Citing Papers
Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of H elicobacter pylori infection
2012
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura
2011
Food‐specific IgG4‐guided exclusion diets improve symptoms in Crohn’s disease: a pilot study
2010
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies forHelicobacter pyloriinfection: an open-label, randomized, single-centre clinical trial
2016
The B-Cell System in Inflammatory Bowel Disease
2006
Chronic Infections and Atherosclerosis
2008
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer
2004
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Secondary immune thrombocytopenic purpura
2007
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
2009
Hypoxia and Inflammation
2011 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review
2009
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Helicobacter pylori Recurrence in Developed and Developing Countries: Meta‐Analysis of 13C‐Urea Breath Test Follow‐Up after Eradication
2008
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis
2006
The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease
2005
The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing
2008 Standout
Crohn's disease
2016 Standout
Helicobacter pylori treatment in the era of increasing antibiotic resistance
2010
Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases
2007
Decay-accelerating Factor Expression May Provide Immunoprotection Against Antibody-mediated Cardiac Allograft Rejection
2008
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Pro- and anti-inflammatory cytokines gene polymorphisms and infection: interactions influence outcome
2004
Helicobacter pylori and Extragastric Diseases – Other Helicobacters
2005
Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens
2004
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Rabeprazole: the role of proton pump inhibitors inHelicobacter pylorieradication
2005
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
2006
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor‐Based Triple Therapy for Helicobacter pylori Eradication: A Meta‐Analysis
2008
Causal Inference Regarding Infectious Aetiology of Chronic Conditions: A Systematic Review
2013
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
2010
Review article: ‘true’ re‐infection of Helicobacter pylori after successful eradication – worldwide annual rates, risk factors and clinical implications
2008
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Effects of CYP2C19 Loss-of-Function Variants on the Eradication of H. pylori Infection in Patients Treated with Proton Pump Inhibitor-Based Triple Therapy Regimens: A Meta-Analysis of Randomized Clinical Trials
2013
Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: A multi‐center randomized controlled trial
2009
Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
2010 Standout
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review
2008
Helicobacter pyloriDetection and Antimicrobial Susceptibility Testing
2007
HIF‐dependent induction of apical CD55 coordinates epithelial clearance of neutrophils
2005
Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer Patients
2005
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Inflammatory Bowel Disease
2010 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Anticancer activities of a chemically sulfated polysaccharide obtained from Grifola frondosa and its combination with 5-Fluorouracil against human gastric carcinoma cells
2006
Edible Mushrooms: Improving Human Health and Promoting Quality Life
2015 Standout
Effects ofMentha suaveolensEssential Oil onChlamydia trachomatis
2015 Standout
Works of Tomoki Inaba being referenced
Increased incidence of allergic disorders and elevated food-specific serum IgG4 levels in Japanese patients with Crohn’s disease
1999
Antibodies against heat shock protein 60 derived from Helicobacter pylori: Diagnostic implications in cardiovascular disease
2007
Reinfection rate following effective therapy against Helicobacter pylori infection in Japan
2002
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype
2002
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection
2003
Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan
2005
Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in Japan.
2008
Decay-accelerating factor (DAF) in stool specimens as a marker of disease activity in patients with ulcerative colitis (UC)
1998
Cytokine-stimulated release of decay-accelerating factor (DAF; CD55) from HT-29 human intestinal epithelial cells
1998
Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC)
1996
Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
2002
Triple Therapy with Ecabet Sodium, Amoxicillin and Lansoprazole for 2 Weeks as the Rescue Regimen for H. pylori Infection
2011